An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A reader posted a short note asking why their knee pain hasn’t improved after about five weeks of using a BPC/TB peptide blend. They describe sharp pain at the top of the kneecap (likely where the quadriceps tendon attaches), in both knees. They report using a “10/10” blend reconstituted with 3 ml bacteriostatic water, giving themselves 15 IU (international units) every morning into belly fat, and they think the intended dose should be 500/500 micrograms. They’re asking what they might be doing wrong. BPC and TB refer to two different peptides people sometimes try for tissue or joint problems. BPC-157 is a small protein fragment that, in lab and animal studies, seems to help tendon and gut healing. TB-500 (thymosin beta-4) is another small protein fragment that has shown effects on cell migration and wound repair in animal research. Importantly, these are experimental for human joint or tendon healing: the strongest evidence comes from animal studies and small, uncontrolled human reports, not large clinical trials. What the report actually shows is a single person’s experience with no formal medical oversight. That means it’s anecdotal — one data point with uncertain dosing and unclear technique. We don’t know exact amounts of each peptide in the “10/10” blend, whether the reconstitution was done correctly, whether the injection volume per dose matched the intended micrograms, or whether 15 IU actually equals the 500/500 mcg target they mentioned. We also don’t know if their diagnosis is correct (tendon pain vs. other knee problems), or whether five weeks is long enough to expect a change. In short, you can’t conclude much from this report except that the person didn’t notice improvement in five weeks. Why this matters to a regular person is twofold. First, people with tendon pain are understandably eager for faster relief, so they may try off-label or experimental treatments found online. Second, dosing, preparation, and correct diagnosis matter a lot for outcomes. If someone is self-administering peptides without clear dosing instructions or medical follow-up, they may be wasting time or delaying safer, proven treatments like physical therapy, load management, or seeing a clinician to confirm the problem. For anyone considering these peptides, it’s useful to have realistic expectations about the limited human evidence and the practical challenges of correct dosing. There are important caveats and risks. BPC-157 and TB-500 are not approved medicines for tendon or knee pain in most places; they’re experimental and often sold without standard quality controls. Injection risks include infection, incorrect dosing, allergic reaction, or injecting into the wrong tissue. Mislabeling or improper reconstitution can change dose strength. People with medical conditions or those on other medications should be cautious and consult a healthcare professional. Finally, lack of improvement in five weeks doesn’t mean the treatment would never work, but it’s a signal to reassess the diagnosis, dosing, and whether a safer, evidence-based plan is needed. Bottom line: One person’s lack of improvement tells us more about uncertainty than about the peptides’ effectiveness; if you’re trying experimental injections, check the diagnosis, confirm dosing and preparation, and talk with a clinician.
Source: r/Peptides